Γλικλαζίδη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Γλικλαζίδη" in Greek language version.

refsWebsite

Global rank Greek rank

6doi.org

2^nd place

3^rd place

5nih.gov

4^th place

4archive.org

6^th place

5^th place

2drugs.com

399^th place

130^th place

2web.archive.org

1^st place

1thepharmajournal.com

low place

1medicines.org.uk

3,823^rd place

2,141^st place

1google.ca

838^th place

220^th place

1who.int

195^th place

72^nd place

1msh.org

low place

8,713^th place

archive.org

British national formulary : BNF 69 (69 έκδοση). British Medical Association. 2015. σελ. 474. ISBN 9780857111562.
Park, J; Kim, KA; Park, PW; Park, CW; Shin, JG (2003). «Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide». Clinical Pharmacology & Therapeutics 74 (4): 334–40. doi:10.1016/S0009-9236(03)00221-2. PMID 14534520. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2003-10_74_4/page/334.
Lawrence, C. L.; Proks, P.; Rodrigo, G. C.; Jones, P.; Hayabuchi, Y.; Standen, N. B.; Ashcroft, F. M. (2001). «Gliclazide produces high-affinity block of K ATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells». Diabetologia 44 (8): 1019–25. doi:10.1007/s001250100595. PMID 11484080. https://archive.org/details/sim_diabetologia_2001-08_44_8/page/1019.
Ballagi-Pordány, György; Köszeghy, Anna; Koltai, Mária-Zsófia; Aranyi, Zoltán; Pogátsa, Gábor (1990). «Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds». Diabetes Research and Clinical Practice 8 (2): 109–14. doi:10.1016/0168-8227(90)90020-T. PMID 2106423. https://archive.org/details/sim_diabetes-research-and-clinical-practice_1990_8_2/page/109.

doi.org

dx.doi.org

Schernthaner, G.; Grimaldi, A.; Di Mario, U.; Drzewoski, J.; Kempler, P.; Kvapil, M.; Novials, A.; Rottiers, R. και άλλοι. (2004). «GUIDE study: Double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients». European Journal of Clinical Investigation 34 (8): 535–42. doi:10.1111/j.1365-2362.2004.01381.x. PMID 15305887.
Park, J; Kim, KA; Park, PW; Park, CW; Shin, JG (2003). «Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide». Clinical Pharmacology & Therapeutics 74 (4): 334–40. doi:10.1016/S0009-9236(03)00221-2. PMID 14534520. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2003-10_74_4/page/334.
Lawrence, C. L.; Proks, P.; Rodrigo, G. C.; Jones, P.; Hayabuchi, Y.; Standen, N. B.; Ashcroft, F. M. (2001). «Gliclazide produces high-affinity block of K ATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells». Diabetologia 44 (8): 1019–25. doi:10.1007/s001250100595. PMID 11484080. https://archive.org/details/sim_diabetologia_2001-08_44_8/page/1019.
Ballagi-Pordány, György; Köszeghy, Anna; Koltai, Mária-Zsófia; Aranyi, Zoltán; Pogátsa, Gábor (1990). «Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds». Diabetes Research and Clinical Practice 8 (2): 109–14. doi:10.1016/0168-8227(90)90020-T. PMID 2106423. https://archive.org/details/sim_diabetes-research-and-clinical-practice_1990_8_2/page/109.
Shimoyama, Tatsuhiro; Yamaguchi, Shinya; Takahashi, Kazuto; Katsuta, Hidenori; Ito, Eisuke; Seki, Hiroyuki; Ushikawa, Kenji; Katahira, Hiroshi και άλλοι. (2006). «Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation». Metabolism 55 (6): 722–30. doi:10.1016/j.metabol.2006.01.019. PMID 16713429.
Grbic, Sandra; Parojcic, Jelena; Ibric, Svetlana; Djuric, Zorica (23 December 2010). «In Vitro–In Vivo Correlation for Gliclazide Immediate-Release Tablets Based on Mechanistic Absorption Simulation». AAPS PharmSciTech 12 (1): 165–171. doi:10.1208/s12249-010-9573-y.

drugs.com

«Gliclazide - Drugs.com». www.drugs.com. Ανακτήθηκε στις 27 Δεκεμβρίου 2016.
«Gliclazide Advanced Patient Information - Drugs.com». www.drugs.com. Ανακτήθηκε στις 27 Δεκεμβρίου 2016.

google.ca

books.google.ca

Fischer, Janos· Ganellin, C. Robin (2006). Analogue-based Drug Discovery (στα Αγγλικά). John Wiley & Sons. σελ. 449. ISBN 9783527607495.

medicines.org.uk

«Bilxona 30mg Modified-release Tablets - Summary of Product Characteristics (SPC) - (eMC)». www.medicines.org.uk. 29 Αυγούστου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Δεκεμβρίου 2016. Ανακτήθηκε στις 27 Δεκεμβρίου 2016.

msh.org

erc.msh.org

«Gliclazide». International Drug Price Indicator Guide. Ανακτήθηκε στις 8 Δεκεμβρίου 2016. ^{[νεκρός σύνδεσμος]}

nih.gov

ncbi.nlm.nih.gov

Schernthaner, G.; Grimaldi, A.; Di Mario, U.; Drzewoski, J.; Kempler, P.; Kvapil, M.; Novials, A.; Rottiers, R. και άλλοι. (2004). «GUIDE study: Double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients». European Journal of Clinical Investigation 34 (8): 535–42. doi:10.1111/j.1365-2362.2004.01381.x. PMID 15305887.
Park, J; Kim, KA; Park, PW; Park, CW; Shin, JG (2003). «Effect of rifampin on the pharmacokinetics and pharmacodynamics of gliclazide». Clinical Pharmacology & Therapeutics 74 (4): 334–40. doi:10.1016/S0009-9236(03)00221-2. PMID 14534520. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_2003-10_74_4/page/334.
Lawrence, C. L.; Proks, P.; Rodrigo, G. C.; Jones, P.; Hayabuchi, Y.; Standen, N. B.; Ashcroft, F. M. (2001). «Gliclazide produces high-affinity block of K ATP channels in mouse isolated pancreatic beta cells but not rat heart or arterial smooth muscle cells». Diabetologia 44 (8): 1019–25. doi:10.1007/s001250100595. PMID 11484080. https://archive.org/details/sim_diabetologia_2001-08_44_8/page/1019.
Ballagi-Pordány, György; Köszeghy, Anna; Koltai, Mária-Zsófia; Aranyi, Zoltán; Pogátsa, Gábor (1990). «Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds». Diabetes Research and Clinical Practice 8 (2): 109–14. doi:10.1016/0168-8227(90)90020-T. PMID 2106423. https://archive.org/details/sim_diabetes-research-and-clinical-practice_1990_8_2/page/109.
Shimoyama, Tatsuhiro; Yamaguchi, Shinya; Takahashi, Kazuto; Katsuta, Hidenori; Ito, Eisuke; Seki, Hiroyuki; Ushikawa, Kenji; Katahira, Hiroshi και άλλοι. (2006). «Gliclazide protects 3T3L1 adipocytes against insulin resistance induced by hydrogen peroxide with restoration of GLUT4 translocation». Metabolism 55 (6): 722–30. doi:10.1016/j.metabol.2006.01.019. PMID 16713429.

thepharmajournal.com

Karmoker, J.R.; Priya, R.J.; Sarkar, S.; Islam, S. (2017). «Comparative in vitro equivalence evaluation of some local Gliclazide brands of Bangladesh». The Pharma Innovation Journal 6: 152-157. Αρχειοθετήθηκε από το πρωτότυπο στις 2017-03-17. https://web.archive.org/web/20170317055115/http://www.thepharmajournal.com/archives/2017/vol6issue3/PartC/6-2-15-510.pdf. Ανακτήθηκε στις 2017-08-15.

web.archive.org

Karmoker, J.R.; Priya, R.J.; Sarkar, S.; Islam, S. (2017). «Comparative in vitro equivalence evaluation of some local Gliclazide brands of Bangladesh». The Pharma Innovation Journal 6: 152-157. Αρχειοθετήθηκε από το πρωτότυπο στις 2017-03-17. https://web.archive.org/web/20170317055115/http://www.thepharmajournal.com/archives/2017/vol6issue3/PartC/6-2-15-510.pdf. Ανακτήθηκε στις 2017-08-15.
«Bilxona 30mg Modified-release Tablets - Summary of Product Characteristics (SPC) - (eMC)». www.medicines.org.uk. 29 Αυγούστου 2016. Αρχειοθετήθηκε από το πρωτότυπο στις 27 Δεκεμβρίου 2016. Ανακτήθηκε στις 27 Δεκεμβρίου 2016.

who.int

«WHO Model List of Essential Medicines (19th List)» (PDF). World Health Organization. Απριλίου 2015. Ανακτήθηκε στις 8 Δεκεμβρίου 2016.